Tumoroids, a valid preclinical screening platform for monitoring cancer angiogenesis
Zahra Abbasi‐Malati, Parisa Khanicheragh, Maryam Taghavi Narmi, Narges Mardi, Nafiseh Didar Khosrowshahi, Amirataollah Hiradfar, Aysa Rezabakhsh, Fatemeh Sadeghsoltani, Somayyeh Rashidi, Sara Aghakhani Chegeni, Golbarg M. Roozbahani, Reza Rahbarghazi
Abstract
In recent years, biologists and clinicians have witnessed prominent advances in in vitro 3D culture techniques related to biomimetic human/animal tissue analogs. Numerous data have confirmed that unicellular and multicellular (tumoroids) tumor spheroids with dense native cells in certain matrices are sensitive and valid analytical tools for drug screening, cancer cell dynamic growth, behavior, etc. in laboratory settings. Angiogenesis/vascularization is a very critical biological phenomenon to support oxygen and nutrients to tumor cells within the deep layer of solid masses. It has been shown that endothelial cell (EC)-incorporated or -free spheroid/tumoroid systems provide a relatively reliable biological platform for monitoring the formation of nascent blood vessels in micron/micrometer scales. Besides, the paracrine angiogenic activity of cells within the spheroid/tumoroid systems can be monitored after being treated with different therapeutic approaches. Here, we aimed to collect recent advances and findings related to the monitoring of cancer angiogenesis using unicellular and multicellular tumor spheroids. Vascularized spheroids/tumoroids can help us in the elucidation of mechanisms related to cancer formation, development, and metastasis by monitoring the main influencing factors.